Ubs Group Ag Beyond Spring Inc. Call Options Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BYSI
# of Institutions
21Shares Held
5.55MCall Options Held
26KPut Options Held
2.4K-
Decheng Capital LLC Menlo Park, CA4.96MShares$8.03 Million2.69% of portfolio
-
Citigroup Inc250KShares$405,0000.0% of portfolio
-
Black Rock Inc. New York, NY215KShares$348,8750.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$47,7460.15% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$39,4760.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $63.1M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...